Evidence map›Paper›PMID 37510015›Full record

ArticleEntropy (Basel, Switzerland)2023

A Two-Phase Feature Selection Method for Identifying Influential Spreaders of Disease Epidemics in Complex Networks.

Xiya Wang, Yuexing Han, Bing Wang

Abstract read
In one paragraph

Article in Entropy (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xiya WangSchool of Computer Engineering and Science, Shanghai University, Shanghai 200444, China.
Yuexing HanSchool of Computer Engineering and Science, Shanghai University, Shanghai 200444, China.ORCID 0000-0002-1170-202X
Bing WangSchool of Computer Engineering and Science, Shanghai University, Shanghai 200444, China.ORCID 0000-0002-7078-4352

Funding

Key Research Project of Zhejiang Laboratory No.2021PE0AC02National Natural Science Foundation of China under Grant No.52273228Natural Science Foundation of Shanghai under Grant No. 20ZR1419000
6 · The paper itself

Abstract

Network epidemiology plays a fundamental role in understanding the relationship between network structure and epidemic dynamics, among which identifying influential spreaders is especially important. Most previous studies aim to propose a centrality measure based on network topology to reflect the influence of spreaders, which manifest limited universality. Machine learning enhances the identification of influential spreaders by combining multiple centralities. However, several centrality measures utilized in machine learning methods, such as closeness centrality, exhibit high computational complexity when confronted with large network sizes. Here, we propose a two-phase feature selection method for identifying influential spreaders with a reduced feature dimension. Depending on the definition of influential spreaders, we obtain the optimal feature combination for different synthetic networks. Our results demonstrate that when the datasets are mildly or moderately imbalanced, for Barabasi-Albert (BA) scale-free networks, the centralities' combination with the two-hop neighborhood is fundamental, and for Erdős-Rényi (ER) random graphs, the centralities' combination with the degree centrality is essential. Meanwhile, for Watts-Strogatz (WS) small world networks, feature selection is unnecessary. We also conduct experiments on real-world networks, and the features selected display a high similarity with synthetic networks. Our method provides a new path for identifying superspreaders for the control of epidemics.

Indexed as

feature selectioninfluential node identificationmachine learningnetwork epidemiology

Identifiers

PMID37510015
PMCPMC10378310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.